Rate My Professor Anthony Gill

AG

Anthony Gill

University of Sydney

4.60/5 · 5 reviews
5 Star3
4 Star2
3 Star0
2 Star0
1 Star0
5.08/20/2025

Helps students build confidence and skills.

4.05/21/2025

Helps students see the joy in learning.

5.03/31/2025

Always positive, enthusiastic, and supportive.

4.02/27/2025

Inspires students to reach new heights.

5.02/4/2025

Great Professor!

About Anthony

Professor Anthony Gill AM, MBBS MD FRCPA, serves as Professor of Surgical Pathology in the Northern Clinical School of the Faculty of Medicine and Health at the University of Sydney. He is a senior staff specialist in anatomical pathology at Royal North Shore Hospital, a position he has held since January 2005. Since January 2012, Professor Gill has led the Cancer Diagnosis and Pathology Research Group at the Kolling Institute of Medical Research and chairs the Australian Pancreatic Cancer Genome Initiative. His academic and research interests center on surgical pathology, including hereditary cancer syndromes, endocrine pathology, molecular pathology of cancer, cancer diagnosis, cell biology, and tumor histopathology. Professor Gill is noted for establishing diagnostic criteria for tumours that are applied internationally. He also leads clinical pathology teaching at the University of Sydney, contributing significantly to medical education.

Professor Gill's research has produced high-impact publications, such as co-authorship on "Signatures of mutational processes in human cancer" (Nature, 2013; over 11,000 citations), "The immune landscape of cancer" (Immunity, 2018; nearly 6,000 citations), "The 2016 WHO classification of tumours of the urinary system and male genital organs" (over 5,000 citations), "The 2019 WHO classification of tumours of the digestive system" (over 4,000 citations), and "Genomic analyses identify molecular subtypes of pancreatic cancer" (Nature, 2016; over 4,000 citations). Recent works include studies on symptom phenotypes in small-bowel neuroendocrine tumours (2026), adjuvant chemotherapy for intraductal papillary mucinous neoplasms (2026), and updates to WHO classifications of genetic tumour syndromes and digestive system tumours. His contributions have earned prestigious honors, including the Member of the Order of Australia (AM), the 2023 NSW Premier's Award for Outstanding Cancer Researcher of the Year, the Distinguished Pathologist Award (2022), and recognition as a world-leading researcher in pathology by The Australian (2024). Professor Gill's work profoundly influences global cancer pathology standards and diagnostics.

Professional Email: anthony.james.gill@sydney.edu.au

    Rate My Professor: Anthony Gill | University of Sydney | AcademicJobs